Note 9 – Stockholders' Deficit

Preferred Stock

As of March 31, 2020 and 2019, there were no shares of the Company's par value $0.0001, 50,000,000 shares, of authorized preferred stock outstanding.

Common Stock

On August 13, 2018, the Company issued 600,000 shares of its $0.0001 par value common stock, with a fair value of $240,000 or $0.40 per share, in connection with its August 13, 2018, senior secured convertible note.

On May 7, 2019, the Company terminated a consulting agreement, which was initially dated September 17, 2018. The Company had engaged the consultant to serve as the exclusive placement agent in the offering of the Company's securities. On May 8, 2019, as consideration for termination of the agreement, the Company issued 346,338 warrants to purchase shares of its common stock at a fair value of $182,520, and issued 100,000 shares of its common stock at a fair value of $82,000 or $0.82 per share.

During the year ended March 31, 2020, the Company issued 473,333 shares of its common stock with a fair value of $0.75 per share, or $355,000, in connection with consulting agreements for advisory services related to corporate strategies.

During the year ended March 31, 2020, the Company issued 876,000 shares of its par value $0.0001 common stock in connection with the Company's convertible notes for a weighted average fair value of approximately $662,000, or $0.75 per share (See Note 8).

 Additional Paid-in Capital

During the year ended March 31, 2019, the Company recorded a beneficial conversion feature of $148,171 related to its convertible notes issued for the period May 2018 through March 2019.

During the year ended March 31, 2020, the Company recorded a beneficial conversion feature of $260,078 related to its convertible notes issued for the period April 2019 through March 2020.